Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Invested Capital (2021 - 2025)

Journey Medical's Return on Invested Capital history spans 4 years, with the latest figure at 0.08% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital changed N/A year-over-year to 0.08%, compared with a TTM value of 0.08% through Dec 2025, changed N/A, and an annual FY2025 reading of 0.06%, up 28.0% over the prior year.
  • Return on Invested Capital for Q4 2025 was 0.08% at Journey Medical, up from 0.21% in the prior quarter.
  • The five-year high for Return on Invested Capital was 2.75% in Q3 2021, with the low at 2.33% in Q4 2021.
  • Average Return on Invested Capital over 4 years is 0.43%, with a median of 0.62% recorded in 2022.
  • Biggest YoY gain for Return on Invested Capital was 172bps in 2022; the steepest drop was -345bps in 2022.
  • Tracing DERM's Return on Invested Capital over 4 years: stood at 2.33% in 2021, then skyrocketed by 74bps to 0.61% in 2022, then skyrocketed by 86bps to 0.08% in 2023, then grew by 9bps to 0.08% in 2025.
  • Per Business Quant, the three most recent readings for DERM's Return on Invested Capital are 0.08% (Q4 2025), 0.21% (Q3 2025), and 0.31% (Q2 2025).